National

Telus buying LifeWorks in deal valued at $2.9B

Darpan News Desk The Canadian Press, 16 Jun, 2022 09:36 AM

VANCOUVER - Telus Corp. has signed a deal to buy LifeWorks Inc. valued at $2.9 billion including debt.

LifeWorks, formerly known as Morneau Shepell, helps companies with employee and family assistance plans, absence management, pension and benefits administration and retirement planning.

Under the agreement, LifeWorks shareholders will have the option to receive $33 in cash or 1.0642 Telus shares for each LifeWorks share held, subject to pro-ration.

The amount of cash and number of shares will be limited so that Telus will pay for half the deal in cash and half in shares.

LifeWorks shares closed at $18.20 on the Toronto Stock Exchange on Wednesday. Telus shares closed at $29.36.

The deal requires support by a two-thirds majority vote by LifeWorks shareholders as well as court and other regulatory approvals.

Prev Next

MORE National ARTICLES

Feds give another $2B to address health backlogs

The money, included in the newly tabled Bill C-17, follows a $4-billion top-up to the federal health transfer last summer and is expected to be a one-time payment, distributed equally based on population.

Feds give another $2B to address health backlogs

ICBC relief rebate coming for drivers

Most ICBC customers with a basic auto insurance policy during the month of February will be eligible for the $110 relief rebate. Most commercial customers will receive a rebate of $165 because they generally incur higher expenses.

ICBC relief rebate coming for drivers

Climate protests planned across Canada today

Dozens of other events are planned in cities across Canada, including Quebec City, Calgary and Vancouver. Using the hashtag #Peoplenotprofit, organizers are denouncing the role of colonialism and capitalism in causing climate change and are calling for reparations to be paid to those most impacted.

Climate protests planned across Canada today

WHO rejects made-in-Canada COVID-19 vaccine

Health Canada authorized Medicago's two-dose Covifenz vaccine in February for adults 18 to 64. In clinical trials it was more than 70 per cent effective at preventing COVID-19 infections and 100 per cent effective against severe illness, before the Omicron wave.

WHO rejects made-in-Canada COVID-19 vaccine

Cautious optimism from privacy czar on CLOUD Act

The federal privacy commissioner says any agreement would need to have "explicit safeguards" to protect the rights of Canadians. Daniel Therrien's office says such an agreement would be an improvement over the current status quo, given the reach of new federal laws in the U.S.

Cautious optimism from privacy czar on CLOUD Act

Surrey RCMP investigating a shooting in Newton area

A male victim with non-life threatening injuries was located. The male was transported to local hospital. Surrey RCMP General Investigation Unit has taken conduct of the investigation.